These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Neurotransmitters behind pain relief with transcranial magnetic stimulation - positron emission tomography evidence for release of endogenous opioids. Lamusuo S; Hirvonen J; Lindholm P; Martikainen IK; Hagelberg N; Parkkola R; Taiminen T; Hietala J; Helin S; Virtanen A; Pertovaara A; Jääskeläinen SK Eur J Pain; 2017 Oct; 21(9):1505-1515. PubMed ID: 28493519 [TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Weerts EM; Wand GS; Kuwabara H; Munro CA; Dannals RF; Hilton J; Frost JJ; McCaul ME Alcohol Clin Exp Res; 2011 Dec; 35(12):2162-73. PubMed ID: 21689118 [TBL] [Abstract][Full Text] [Related]
9. Ethnic disparities in pain processing among healthy adults: μ-opioid receptor binding potential as a putative mechanism. Letzen JE; Mun CJ; Kuwabara H; Burton EF; Boring BL; Walls T; Speed TJ; Wong DF; Campbell CM Pain; 2020 Apr; 161(4):810-820. PubMed ID: 31764386 [TBL] [Abstract][Full Text] [Related]
10. Placebo effects on human mu-opioid activity during pain. Wager TD; Scott DJ; Zubieta JK Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11056-61. PubMed ID: 17578917 [TBL] [Abstract][Full Text] [Related]
11. Altered Signaling in the Descending Pain-modulatory System after Short-Term Infusion of the μ-Opioid Agonist Remifentanil. Sprenger C; Eichler IC; Eichler L; Zöllner C; Büchel C J Neurosci; 2018 Mar; 38(10):2454-2470. PubMed ID: 29440535 [TBL] [Abstract][Full Text] [Related]
12. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Love TM; Stohler CS; Zubieta JK Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703 [TBL] [Abstract][Full Text] [Related]
14. Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence. Bencherif B; Wand GS; McCaul ME; Kim YK; Ilgin N; Dannals RF; Frost JJ Biol Psychiatry; 2004 Feb; 55(3):255-62. PubMed ID: 14744466 [TBL] [Abstract][Full Text] [Related]
15. Dissociable Roles of Cerebral μ-Opioid and Type 2 Dopamine Receptors in Vicarious Pain: A Combined PET-fMRI Study. Karjalainen T; Karlsson HK; Lahnakoski JM; Glerean E; Nuutila P; Jääskeläinen IP; Hari R; Sams M; Nummenmaa L Cereb Cortex; 2017 Aug; 27(8):4257-4266. PubMed ID: 28541428 [TBL] [Abstract][Full Text] [Related]
16. Low- and high-frequency transcutaneous electrical acupoint stimulation induces different effects on cerebral μ-opioid receptor availability in rhesus monkeys. Xiang XH; Chen YM; Zhang JM; Tian JH; Han JS; Cui CL J Neurosci Res; 2014 May; 92(5):555-63. PubMed ID: 24482187 [TBL] [Abstract][Full Text] [Related]
17. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
18. Naloxone-induced cortisol predicts mu opioid receptor binding potential in specific brain regions of healthy subjects. Wand GS; Weerts EM; Kuwabara H; Frost JJ; Xu X; McCaul ME Psychoneuroendocrinology; 2011 Nov; 36(10):1453-9. PubMed ID: 21549509 [TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). Harris RE; Zubieta JK; Scott DJ; Napadow V; Gracely RH; Clauw DJ Neuroimage; 2009 Sep; 47(3):1077-85. PubMed ID: 19501658 [TBL] [Abstract][Full Text] [Related]
20. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system. Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]